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Treatment of mouse embryonal carcinoma (F9) cells with retinoic acid, an inducer of F9 cell differentiation, greatly increased the level of mRNA 
specific to one of the heal-shock proteins (NSP86). Experiments including the one employing differentiation-resistant mutant F9 cells suggested 
that the increase represents early molecular events associated with the embryonal differentiation. The increased HSP86 mRNA declined to the 
original level during further incubation. The presence of cyclic AMP, which stimulates conversion of the retinoic acid-induced primitive endoderm 
cells to parietal endoderm cells, prevented the decline. These results suggest that not only the elevation of HSP86 mRNA level represents early 
molecular events in F9 cell differentiation but also that sustaining the elevated level (by cyclic AMP) is associated with further differentiation of 
the embryonal cells. 
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1. INTROBIJCTION 
Three major groups of heat-shock proteins (HSP), 
proteins with mol. mass of 20-30, 68-73 and 80-90 
kDa, are widely distributed throughout living or- 
ganisms from bacteria to mammals, suggesting their 
ubiquitous roles in fundamental cellular functions. 
Among them, HSP with mol. mass of 68-73 kDa 
(HSP’SO) are believed to play a critical role in safeguard- 
ing the cells from damages caused by stresses such as 
heat shock [1,2]. On the other hand, the biological role 
of HSP with mol. mass of 80-90 kDa (HSPBO), one of 
the most abundant protein species which comprises two 
major protein classes (HSPW and I-lSP86), still remains 
largely unknown. A limited number of biochemical 
reactions known to involve HSP90 include the forma- 
tion of complexes with steroid hormone receptors [3-63 
or tyrosine kinases [7-l 11. A suggestion was made that 
HSP90 is required for intracellular protein transport 
WI. 
In order to explore the possibility that HSP90 may be 
involved in the molecular cascade in cellular differentia- 
tion, we examined the level of l-BP90 mRNA during in 
butyryl) cyclic AMP, which stimulates the conversion of 
primitive endoderm cells to parietal endoderm cells in 
the F9 embryonal differentiation lineage [IS], prevented 
the decline and kept H§P86 mRNA at the elevated level 
for several days. A possible role of HSP86 mRNA in F9 
differentiation is discussed. 
2. MATERIAES AND METHODS 
2.1. Materials 
Herbimycin A was kindly supplied by Dr Y. Uehara. Retinoic acid 
and dibutyryl cyclic AMP were purchased from Sigma (St. Louis, 
MO). All the other agents were reagent-grade. ES medium was pur- 
chased from Nissui Seiyaku (Tokyo). Fetal calf serum was obtained 
from Sigma [32P]dCTP and [“S]methionine were purchased from ICN 
Biomedicals (Irvine, CA). 
2.2. Cells and cell culture 
F9 cells were supplied by Dr Y. Nishimune. Differcntiation-resi- 
stant mutant cell lines @A’-6 and RA’-OT) were isolated from N- 
methyl-N’-nitro-N-nitrosoguanidine-treated F9 cells as will be de- 
scribed 1141. The cells were cultured at 37°C in a CO2 (5%) incubator 
in ES medium supplemented with FCS (10% (vol/vol)). Plastic tissue 
culture dishes had been coated with gelatin solution (0.4% (wtlvol)) 
before use. 
2.3. Isolation q/a HSP90 EDNA clone (pMHS86) 
For the isolation of HSP90 clone (pMHS86), which was used as a 
vitro differentiation of mozsc cmbrvonal carcinoma 
(F9) cells. Here we report that the-mRNA level of 
HSP86, a major class of HSPBO, increased significantly 
at the very early stage of F9 differentiation triggered by 
retinoic acid, but the level declined sharply to the pre- 
treatment level after several hours. The presence of (di- 
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cDNA library was lirsi constructed from RNA isolated from F9 cells 
probe for Northern hybridization to detect HSP86 mRNA, a &t 10 
which had been incubated with herbimycin A (0.5 &ml) for 6 h. 
Sequencing of a clone @H707), which was derived from an mRNA 
species specific to at the early stage of F9 differentiation, showed that 
the clone contained sequences identical with part of the HSP86 gene 
[15], a major HSP90 member. Using dH707 as a probe, a new clone 
(pMHS86) with more complete HSP86 sequences including 5’.non- 
coding region was isolated from the mouse Okayama-Berg library. A 
portion of pMHS86 (total 380 bp) between X/z01 (in the vector) and 
Bg/l (5’ side of the initial ATG) specific to HSP86 was used as the 
probe for Northern hybridization. 
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2.4. Norlhern hybridization mRNk at least at this very early stage of differentiation 
RNAs were prepared from the cytoplasmic fraction of F9 cells (-10’ 
cells) according to the method described by Wisnievski et al. [16]. 
Northern hybridization was performed as described [l7]. RNA (5 peg) 
was electrophoresed through agarose gel (I%), transferred to nylon 
membrane filters and hybridized with pMHS86 or chicken B-actin- 
probe @Al) [IS] which had been labeled with [‘“P]dCTP (ICN) by 
random priming [ 191. 
2.5. Autoradiography ofproteins 
F9 cells were labeled with [“S]methionine (ICN, 200 @Cilml, 3000 
Wmmol) for 30 min as indicated in the legend to Fig. 4. The cells were 
lysed and the samples were subjected to SDS-PAGE (7.5% acryla- 
mide) [to] and autoradiography using Kodak X-QMAT films. 
(Fig. lA, lane 3, and see below). - 
In order to determine whether the increase of HSPg6 
transcripts following retinoic acid treatment represen- 
ted early molecular events of F9 cell differentiation or 
the increase was a result of specific and direct ‘activation 
of the HSP86 gene by retinoic acid, we also examined 
th,e level of HsP86 transcripts in the cells which had 
been treated with herbimycin A, an inhibitor of tyrosine 
protein kinase [2X24] and another potent inducer of F9 
cell differentiation. Herbimycin A, even without (dibu- 
3. RESULTS AND DISCUSSION 
effect on the retinoic acid-induced increase of HSPg6 
Mouse embryonal carcinoma (F9) cells differentiate 
in vitro into primitive endoderm-like cells following ex- 
129 
posure to retinoic acid [21]. The presence of (dibutyryl) 
1 2 
28s P 
cyclic AMP further stimulates the differentiation into 
““G”, xf-- * 
parietal endoderrn-like cells [ 131. In order to explore the 
possible role of heat-shock proteins, particula.rly of 
HSP90, in embryonal differentiation, we treated F9 cells 
with retinoic acid and RNA was subjected to Northern 
blot hybridization after electrophoresis using a HSPBO 
probe (pMIIS86) which represented Y-non-coding re- 
gion unique to the HSPg6 gene. As seen in Fig. IA, 
RNA isolated after a 6-h incubation with retinoic acid 
gave a considerably higher signal than the control RNA 
from untreated cells. The presence of (dibutyryl) cyclic 
AMP in addition to retinoic acid apparently had no 
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Fig. I. Change of HSP86 mRNA levels during P9 differentiation, A. 
F9 cells were incubated with retinoic acid (I PM) or retinoic acid (1 
PM) plus dibutyryl cyclic AMP (0.5 mM) for 0 and 6 h. RNA was 
isolated from each sample (-IO7 cells) and subjected to Northern blot 
hybridization using 32P-labeled HSP86 probe (pMHS86) or P-actin 
probe (pAI). The positions of HSP86 mRNA, fl-actin mRNA and 
molecular weight markers (18s 28s ribosomal RNA) are indicated. 
For details, see section 2. Lane I, control cells (0 h); lane 2, cells 
incubated with retinoic acid for 6 : lane 3, ceils incubated with retinoic 
acid plus dibutyryl cyclic AMP for 6 h. B. Sameas A, but F9 cells were 
incubated with herbimycin A (0.5 ,&$ml) for 0 and 6 h. Lane I, control 
cells (0 h); lane 2, cells incubated with herbimycin A for 6 h. For 
details, see above and section 2, 
Fin. 2. HSP86 mRNA levels in differentiation-resistant F9 mutant 
cells. A. Differentiation-resistant F9 mutant cells (RA’-6and RA’-OT) 
were incubated in the presence of retinoic acid (I PM) or retinoic acid 
(I PM) plus dibutyryl cyclic AMP (0.5 mM) for 0, 6 and 96 h. RNA 
was isolated from each sample (-10’ cells) and subjected to Northern 
blot hybridizatioii as described in the legend to Fig. 1 and section 2. 
Lane l-5, RNAs from RA’-6; lane 6-10, RNAs from RA’-OT. Lane 
I and 6, control (0 h); lane 2 and 7, cells incubated with retinoic acid 
for 6 h; lane 3 and 8, cells incubated with retinoic acid plus dibutyryl 
cyclic AMP for 6 h; lane 4 and 9, cells incubated with retinoic acid for 
96 h and lane 5 and IO, cells incubated witli retinoic acid plus dibutyryl 
cyclic AMP for 96 h. B. Same as A, but RA’-6 and RA’-OT cells were 
incubated in the presence of herbimycin A (0.5 @g/ml) for 0, 6 and 96 
h, Lane 1-3, RNAs from RA’-6; and lane 4-6, RNAs from RA’-OT. 
Lane I and 4, control (0 It); lane 2 and 5, cells incubated with herbi- 
mycin A for 6 h; and lane 3 and 6, cells incubated with herbimycin A 
for 96 h. The positions of HSP86 mRNA, p-actin mRNA and molec- 
ular weight markers (18s and 28s ribosomal RNA) are indicated. For 
details, see the legend to Fig. I and section 2. 
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associated with F9 cell differentiation, particularly that 
involved at the very early stage of differentiation. 
After the initial rather dramatic increase, however, 
the HSP86 mRNA levels remained at that elevated level 
only transiently, having declined to the pretreatment 
level during further incubation (Fig. 3). Interestingly, 
the decline, which occurred between 1% h and 24 h after 
exposure to retinoic acid, was blocked when (dibutyryl) 
cyclic AMP was present in the culture medium. As de- 
scribed above, (dibutyryl) cyclic AMP is known to 
stimulate the conversion of retinoic acid-induced primi- 
tive endoderm-like cells to parietal endoderm-like cells 
in the F9 differentiation lineage. As seen in Fig. 3, the 
presence of (dibutyryl) cyclic AMP in addition to reti- 
naic acid kept the HSP86 mRNA levels to be elevated 
as long as for 96 h, during which the cells were conver- 
ted to parietal endoderm-like cells. Incubation of the 
cells with (dibutyryl) cyclic AMP alone did not increase 
the I-BP86 mRNA levels over the control levels (data 
not shown). The decline of HSP86 mRNA levels seemed 
irreversible, for the addition of (dibutyryl) cyclic AMP 
to the culture medium after the decline (for example, 
addition after 48 h incubation with retinoic acid) had no 
effect (data not shown). Furthermore, in the herbimycin 
A-treated cells, in which the cells directly differentiate 
to parietal endoderm-like cells, no such decline of 
HSP86 mRNA levels was observed even after pro- 
longed incubation (data not shown). Thus, one could 
speculate that sustaining the elevated HSPS6 mRNA 
levels is necessary for or at least associated with further 
F9 cell differentiation into parietal endoderm-like cells. 
We also examined the rate of synthesis of HSP86 gene 
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tyryl) cyclic AMP, triggers F9 cell differentiation and 
converts F9 cells into cells which are very similar to 
parietal endoderm cells /25]. In Fig. IB, we show the 
results of Northern blot hybridization with RNA ex- 
tracted from herbimycin A-treated cells. It was quite 
clear that the level of HSP86 transcripts also increased 
significantly after incubation with herbimycin A. These 
results suggest hat the increase of I-BP86 mRNA levels 
is one of the early events associated with F9 cell diffe- 
rentiation rather than the result of specific activation of 
HSP86 gene by retinoic acid. The level of mRNA speci- 
fic to another major heat-shock protein, HSP’SO, was 
not affected either by retinoic acid or herbimycin A 
treatment (data not shown). 
To further investigate the possible association of the 
increase of HSP&6 mRNA level with F9 differentiation, 
two mutant F9 cells @A’-OT and RN-6), which were 
resistant o retinoic acid-induced differentiation but still 
sensitive to herbimycin A-induced differentiation, were 
isolated. Detailed characteristics of these F9 mutant 
cells will be reported elsewhere [14]. The mutant cells 
were exposed to retinoic acid and RNA extracted from 
them was subjected to Northern blot hybridization. No 
apparent increase of HSP86 transcripts was observed 
up to 96 h incubation with retinoic acid (Fig. 2A). On 
the other hand, the level of HSP86 mRNA in these 
mutant cells increased considerably by herbimycin A 
treatment which led the mutant cells to normal differen- 
tiation (Fig. X3). The basal level of the transcripts in the 
mutant cells without the drug treatment was almost 
equal to that of the parental cells (data not shown, aiso 
compare lane 1 in Fig. 1B with lanes 1 and 4 in Fig. 2B). 
Taken together, it seems that the early increase of 
HSP86 mRNA levels after exposure of the cells to reti- 
noic acid (or herbimycin A) is a phenomenon closely 
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Fig. 3. HSP86 mRNA level as a function of incubation time and the 
effect of (dibutyryl) cyclic AMP. F9 cells were incubated in the pres- 
ence of retinoic acid (1 FM) or retinoic acid (1 PM) plus dibutyryl 
cyclic AMP (0.5 mM). At 0, 3, 6, 12, 24? 36, 48 and 96 h, RNAs were 
extracted from -1O’cells and subjected to Northern blot hybridization 
as described in the legend to Fig. 1 and section 2, Time (incubation 
time; hours) and present (+) or absence (-) of dibutyryl cyclic AMP 
in the medium in addition to retinoic acid are indicated as well as the 
positions of HSP86 mRNA, p-actin mRNA and molecular weight 
markers (18s and 28s ribosomal RNA). For details. see section 2, 
Fig. 4. Analysis of cellular proteins by autoradiography, F9 cells were 
incubated in the presence of retinoic acid (I PM) or retinoic acid (1 
,uM) plus dibutyryl cyclic AMP (0.5 mM). At 0, 6 and 96 h, the cells 
were pulse-labeled with [35S]methionine (200 ,@i/ml) for 30 min. The 
cells WC~C then lyscd, and the samples were subjected to SDS-PAGE 
and autoradiography. The positions of HSP86 and HSP84 are indi- 
cated. 
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product, HSP86 protein, during F9 differentiation. Pn 
contrast to H§P86 mRNA, to our surprise, the rate of 
incorporation of ]3SS]methionine into HSP86 (and 
HSP84) remained relatively constant during the differ- 
entiation and no effect of (dibutyryf) cyclic AMP was 
observed (Fig. 4). Several possibilities can be considered 
to explain these results. Moore et al. have recently re- 
ported that a HSP86 probe hybridized with sequences 
located on three separate chromosomes suggesting that 
the HSP86 gene comprises three HSP86 family rnem- 
bers which may include HSP86 pseudogenes [15]. It is, 
therefore, possible that the increased HSP86 mRNA 
observed during F9 embryonaf diff’erentiatiou was 
derived from one of these genes, the transcription prod- 
uct of which is not translated. Alternatively, HSP86 
gene expression may be regulated by an, as yet, un- 
known mechanism because the 5’-non-coding region of 
the HSP86 gene contained extraneous ATG triplets, 
quite an unusual feature observed in eukaryotic mRNA 
/15]. The other possibilities include the one which as- 
sumes a mechanism to maintain the rate of HSP86 
protein synthesis relatively constant despite the con- 
siderabfe change in the HSP86 mRNA level. In any 
event, the present experiments indicated that the level 
of HSP86 transcripts changes in a manner closely as- 
sociated with F9 cell differentiation and the presence of 
(dibutyryf) cyclic AMP sustains this level to be elevated 
which may be closely associated with the further dif- 
ferentiation of F9 cells from retinoic acid-induced 
primitive endoderm-like cells to parietaf endoderm-like 
calls. 
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